Inclacumab Biosimilar – Anti-SELP mAb – Research Grade

Reference:
Size

,

Isotype

IgG4, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameInclacumab Biosimilar - Anti-SELP mAb - Research Grade
SourceCAS 1256258-86-2
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsInclacumab,LC1004-002,RO4905417,SELP,anti-SELP
ReferencePX-TA1279
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody

Description of Inclacumab Biosimilar - Anti-SELP mAb - Research Grade

General information on Anti-SELP[Homo sapiens] (Inclacumab) Monoclonal Antibody

Inclacumab has investigated for the treatment and prevention of Myocardial Infarction, Peripheral Arterial Disease (PAD), and Coronary Heart Disease.

SDS-PAGE for Inclacumab Biosimilar - Anti-SELP mAb

Inclacumab Biosimilar - Anti-SELP mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Inclacumab Biosimilar – Anti-SELP mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human CD62P-SELP recombinant protein
Antigen

Human CD62P-SELP recombinant protein

PX-P6095 420€
Inclacumab ELISA Kit
ELISA

Inclacumab ELISA Kit

KPTX192 1300€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products